The Food and Drug Administration (FDA) has confirmed that Sinovac of China has passed the evaluation of the vaccine experts panel of the Philippines.
According to FDA Director General Eric Domingo, they are only waiting for Sinovac to submit its application for the Phase 3 clinical trial in the country.
However, the vaccine must first pass the ethics board to ensure the protection of the participants of the trial. Sinovac clinical trials in the country might start in November.
“I think that’s the best case scenario, first quarter next year that there’s a vaccine that’s already registered not only in the Philippines but in other countries as well.”
Report from Mark Fetalco
